See if you prequalify

My cervical cancer may be back, but I won’t stop fighting.

Learn about a clinical trial for recurrent or metastatic cervical cancer.

See if you prequalify * The information you provide will be kept confidential. ?

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

Close

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

top banner
top banner
top banner
top banner
top banner

About the innovaTV 301 study

The innovaTV 301 study is testing a study drug, tisotumab vedotin, for people with cervical cancer that has spread or has come back after treatment. During the study, participants will receive either the study drug or chemotherapy treatment for cervical cancer. This study drug works in a new way and is designed to target cervical cancer cells.

See if you prequalify * The information you provide will be kept confidential. ?

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

Close

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

How do I qualify?

You may qualify if you have been diagnosed with cervical cancer that has spread (metastasized) or come back (recurrent) after your treatment.

The study doctor can discuss any additional criteria with you.

qualify image

Why take part?

You will get the following at no extra cost:

  • Either the study drug or standard chemotherapy (with a 50/50 chance of receiving one or the other)
  • All study-related medical exams
  • Close monitoring of your cancer and overall health by doctors who specialize in cervical cancer

You may be paid back for some of your travel and lodging costs.

qualify image

Your safety is the highest priority while participating. If you have questions or concerns at any point throughout the study, a study staff member is available. Your participation is voluntary, and you are free to withdraw at any time and for any reason. Your privacy will be maintained throughout the study.

See if you prequalify * The information you provide will be kept confidential. ?

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

Close

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

About Cervical Cancer

Cervical cancer is a type of cancer that occurs in the cells of the cervix — the lower part of the uterus that connects to the vagina.1 It is the fourth most common cancer in women. In 2018, an estimated 570,000 women were diagnosed with cervical cancer worldwide.2 Treatments for cervical cancer may include surgery, radiation, and drug therapies. Depending on the type and stage of your cancer, you may have already had 1 or more of these treatments.3

See if you prequalify * The information you provide will be kept confidential. ?

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

Close

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

Frequently Asked Questions

This section will help answer some important questions you may have.

About the innovaTV 301 study

About Clinical Trials

See if you prequalify * The information you provide will be kept confidential. ?

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

Close

If you prequalify and give your permission, your information will be forwarded to a member of the study team. They will contact you to discuss more information about participation.

References:

  1. Cervical Cancer: Overview. Mayo Clinic Website. https://www.mayoclinic.org/diseases-conditions/cervical-cancer/symptoms-causes/syc-20352501. Accessed April 14, 2021.
  2. Health Topics: Cervical Cancer. World Health Organization website. https://www.who.int/health-topics/cervical-cancer#tab=tab_1. Accessed April 14, 2021.
  3. Cervical Cancer: Treating Cervical Cancer. American Cancer Society website. https://www.cancer.org/cancer/cervical-cancer/treating.html. Accessed April 14, 2021.